Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway

• 主要な著者: Zhihang Chen (著者), Chun Wang (著者), Hao Dong (著者), Xing Wang (著者), Feng Gao (著者), Sen Zhang (著者), Xiaolong Zhang (著者)
• フォーマット: 図書
• 出版事項: BMC, 2020-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background Aspirin, as a non-steroidal anti-inflammatory drug, can improve the survival rate of patients with colorectal cancer, while aspirin is effective in patients with PIK3CA mutant colorectal cancer (CRC). However, the mechanism of aspirin in the treatment of PIK3CA mutated CRC patien...